We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

3 FTSE 100 and FTSE 250 value stocks I’d buy right now

The London Stock Exchange is packed with top value stocks offering low earnings multiples and big dividend yields. These three are on my shopping list.

| More on:
Smiling family of four enjoying breakfast at sunrise while camping

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

I’m searching the FTSE 100 and FTSE 250 for the best value stocks that money can buy. Here are three I’ll be looking to add to my portfolio when I have extra cash to invest.

GSK

Should you buy GSK shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

Failure at the lab bench can play havoc with drugs developers’ profits. Yet a growing global population and rising healthcare spending in developing countries provide a wealth of opportunities for such businesses.

FTSE 100 share GSK (LSE:GSK) is one such on my radar. It has a phenomenal track record of getting its products past regulators and onto pharmacy shelves. And it’s investing heavily in fast-growing therapy areas like vaccines, oncology and respiratory to give earnings an additional boost.

The company’s sale of $804m worth of Haleon shares late last week gives GSK’s shares extra appeal, too. The extra funds give it additional financial firepower to invest in its product pipeline. They also give it more balance sheet strength to pay decent dividends to its shareholders.

Today GSK’s share price commands a forward price-to-earnings (P/E) ratio of 10 times. They also carry a healthy 3.8% prospective dividend yield, proving attractive all-round value.

NCC Group

IT services businesses like NCC Group (LSE:NCC) haven’t had the best of times more recently. This UK share — an expert in the field of cyber security — cut its profit forecasts just over a month ago chiefly due to trouble in North America.

Tech sector troubles have caused clients to cancel or delay buying decisions, the firm said, while further interest rate rises had also sapped customer appetite. The collapse of Silicon Valley Bank had damaged tech market confidence and thus project spending, too.

But I believe these troubles are baked into NCC’s low share price. For the year to May 2024 the FTSE 250 firm trades on a P/E ratio of just 8 times.

As a long-term investor I find its shares highly attractive at current prices. Fixing cyber attacks is an expensive business (outsourcing giant Capita recently said that a security breach could cost it £20m). And the threat from hackers is steadily growing as the world becomes increasingly digitalised. I expect NCC to recover strongly from its current troubles.

TBC Bank Group

I’ve long had my eye on TBC Bank Group (LSE:TBCG) shares. I feel the company’s leading position in Georgia’s fast-growing banking industry could deliver exceptional returns. And following this week’s sizzling market update I’m considering finally adding it to my portfolio.

Net interest income and pre-tax profit soared 27% and 19% respectively in the first quarter. This was driven by rapid growth in the Georgian economy (7.2% during the period) and a jump in customer numbers (up 42% year on year to 14.8m).

Okay, banks are highly cyclical and growth at TBC could stall if the global economy encounters a fresh crisis. Yet in my opinion the FTSE 250 firm’s low valuation still makes it a top-class value stock to buy.

Today it trades on a forward P/E ratio of 3.9 times. It also sports a terrific 8.2% prospective dividend yield.

Royston Wild has no position in any of the shares mentioned. The Motley Fool UK has recommended GSK and Haleon Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Close-up as a woman counts out modern British banknotes.
Investing Articles

How to buy growth stocks at below-market prices

Don’t want to pay market prices for growth stocks? Here's a sneaky strategy investors can use to get deals at…

Read more »

CEO Mark Zuckerberg at F8 2019 event
Investing Articles

Are Meta shares at the start of a comeback?

Shares in Meta Platforms have been held back by the firm’s high-risk approach to AI. But is this the moment…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

With dividend yields averaging above 7%, are these 2 UK shares worth considering?

Muhammad Cheema looks at two UK shares: ITV and Legal & General. With yields of 6.1% and 8.1%, should investors…

Read more »

Close-up as a woman counts out modern British banknotes.
Investing Articles

How much do you need to invest in dividend stocks to be able to retire?

Some 77% of people in the UK won't have enough income to manage a moderate retirement. Here’s how dividend stocks…

Read more »

Abstract bull climbing indicators on stock chart
Investing Articles

FTSE 250 stock CMC’s shares have rocketed 51%! What’s going on?

CMC Markets' shares have surged by double-digits today after a strong full-year trading update. Is the FTSE 250 company now…

Read more »

A row of satellite radars at night
Investing Articles

Will I buy SpaceX at £100 a share in my SIPP?

Ben McPoland is considering adding SpaceX stock to his SIPP on 12 June. Might this be a no-brainer buy-and-hold opportunity?

Read more »

Young brown woman delighted with what she sees on her screen
Investing Articles

Aberdeen shares are back in the FTSE 100 — is this turnaround stock just getting started?

Following its return to the FTSE 100, Andrew Mackie examines whether Aberdeen's shares could be on the cusp of a…

Read more »

Shot of an young mixed-race woman using her cellphone while out cycling through the city
Investing Articles

Down 65% with a 5.65% yield! Is this dividend share a once-in-a-decade buy? 

Harvey Jones says this dividend share is still posting decent profits at a challenging time. Its low valuation and high…

Read more »